Los Angeles Capital Management LLC Vir Biotechnology, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 13,580 shares of VIR stock, worth $100,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,580
Previous 13,331
1.87%
Holding current value
$100,492
Previous $118,000
14.41%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VIR
# of Institutions
218Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$123 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$97.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$41.6 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$26.4 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $982M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...